Trial intelligence / Profile preview

Comparison of mydriatic effects between four tropicamide + phenylephrine regimens in diabetic patients

TCTR20260320007Phase 4Completed

Sponsor
Burapha University
Start
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of phenylephrine + tropicamide in type 2 diabetes mellitus (T2DM), sponsored by Burapha University. Started Nov 2024; status: completed.

02

Drugs

phenylephrine + tropicamide
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on TCTR20260320007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260320007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call